While reporting financial results for the fourth quarter on Friday, biopharmaceutical company Bristol-Myers Squibb Co. (BMY) provided earnings, adjusted earnings and revenue guidance for the full-year 2022.
from RTT - Earnings https://ift.tt/1srpUXc
via IFTTT
No comments:
Post a Comment